Therole of collagens and collagenreceptors was investigatedin stimulating platelet-dependent thrombin generation.F ibrillar type-I collagens, including collagen from human heart, were most potentinenhancing thrombin generation,inaway dependentonexposureofphosphatidylserine (PS) at the plateletsurface.Soluble,non-fibrillar type-I collagenrequired pre-activation of integrin α 2 β 1with Mn 2+ forenhancementofthrombin generation.With all preparations, blockingo fg lycoprotein VI (GPVI) with9O12 antibody abrogatedthe collagen-enhanced thrombin generation, regardless of the α 2 β 1activation state.Blockadeof α 2 β 1a lone or antagonismo fa utocrine thromboxane A 2 and ADP were less effective.Blockadeof α IIbβ 3with abciximab supKeywords Coagulation, collagen, glycoprotein VI,p latelets,t hrombin generation pressedthrombin generation in platelet-rich plasma, but this did not abolishthe enhancing effect of collagens.Thehigh activity of type-If ibrillarc ollagens in stimulatingG PVI-dependentp rocoagulant activity was confirmedi nw hole-bloodf lows tudies, showingthat these collagens induced relativelyhigh expression of PS.To gether,these results indicate that:i)fibrillartype-I collageng reatlye nhances thrombin generation, ii) GPVI-induced plateletactivation is principallyresponsible forthe procoagulant activity of fibrillarand non-fibrillarcollagens,iii) α 2 β 1and signaling via autocrine mediatorsfacilitateand amplify this GPVIactivity,and iv) α IIbβ 3isnot directlyinvolved in the collagen effect.
Introduction
Plateletbindingtocollagen exposed at adamaged vesselwallis consideredaninitial and keystepinthrombus formation (1) .Two receptors mediate the stableinteraction of platelets with collagen fibers: the adhesive receptor,integrin α 2 β 1, and the signaling receptor,glycoprotein VI (GPVI), whichisamember of the immunoglobulin receptor family; the contribution of additionalreceptorsfor collagenisstill disputed (2) . Bothreceptorsappeartocooperate in collagen-induced thrombus formation: the lowaffinity GPVIreceptor playsanactivating role, e.g.inducing higheraffinity binding sites of integrin α 2 β 1for collagen. The activated integrin, in turn, stabilizes the binding of GPVIand the signaling through this receptor (3) (4) (5) (6) .P articularlya th igh, arterial shear rates,a lso plateletb indingv ia glycoprotein Ib-IX-V to Willebrand factor (VWF,which avidlybinds to collagen) participates in the interplayofcollagen receptors, both directlyand indirectly by stabilization via integrin α IIbβ 3 ( 6, 7) . Additional factors contributing to the stabilization of platelet-collagencontactare the autocrine mediators, thromboxane A 2 (TxA 2 )a nd ADP, whichare both released from activatedplatelets (8, 9) , e.g.byenhancing the α 2 β 1and α IIbβ 3activation (10) . In addition, these secondarym ediatorst rigger nearby, flowing platelets to assemble on the primarylayer of collagen-adherentplatelets with as aresultformation of aplateletthrombus.
Whereas the function and interplayofthese direct and indirect collagenr eceptorsi np lateleta dhesion and aggregate formation is relativelyw ellu nderstood,m uch less is known of the importanceofthese receptors in collagen-induced thrombin generation and coagulation. Earlier data indicate that type-Icollagenfibers stimulate Ca 2+ -dependent shedding of microvesicles and scrambling of plasma membrane phospholipids,with as are-sult expression of procoagulant phosphatidylserine (PS)a tt he surfaceofvesiclesand remnant platelets (11) .The exposed PS is necessary butperhaps notsufficient forplatelets to mediate prothrombinaseactivation, thrombin generation and clotformation (12) .Bycomparing the PS-exposing effect of collagenwith that of more specific GPVI-activating agonists, sucha sc onvulxin and collagen-related peptide, it wasconcludedthat GPVI plays a prominent role in the procoagulant reaction of collagen (13, 14) . This agrees with the observation thatvariation in plateletGPVI content ledt oac orresponding change in GPVI-mediatedp rothrombinaseactivity (15).
Ty pically, in washedp latelets, fibrillar collagenb yi tself is onlyaweak stimulus of the procoagulant plateletresponse. Coactivation of platelets with thrombin is required to obtain significant procoagulant activity with collagen ( 16, 17) . This may implythat, in analogy to collagen-induced aggregate formation, next to GPVIadditional receptors (and ligands) supportPSexpression and thrombin formation; candidate receptors areglycoproteinI b-V-IX( VWF), integrins α 2 β 1a nd α IIbβ 3( fibrinogen),a nd the autocrine mediatorsADP and TxA 2 .Ani ndication that the adhesive receptors indeed contribute to collageninduced procoagulant activity comes fromthe observation that adhesion perseenhances GPVI-inducedPSexpression (18) .Yet, non-fibrillar,soluble collagens with limited GPVI binding sites and to whichp latelets adhere mainlyv ia α 2 β 1( 19), areo nly weak stimulatorsofPSexpression and thrombin formation (20) , whichquestions arole of α 2 β 1inthis response. Further,incollagen-adherent platelets, the autocrine ADP and TxA 2 mediate integrin affinity changes and mayt hus influencec ollagen-inducedPSexpression (6, 10) . Whether and howthese adhesive receptors interact with collagentostimulate procoagulant activity, and what the precise requirement hereinisofthe collagen(fibrillar)structure, are still unresolvedissues.
Here,w eset to studythe contribution of collagenreceptors and autocrine agents in thrombin generation with different collagens under physiologically relevant conditions, in platelet-rich plasma (PRP)that wastriggered with alow dose of tissue factor. To investigatet his, we compared type-I collagenp reparations with different affinities for collagenreceptors, i.e.Hormtype-I collagen(used as reference)and fibrillar and non-fibrillar (soluble) collagens and,i na ddition, ac ollagen enrichedi nt ype-I fibersderivedfrom humanheart.
Materialand methods

Materials
Abciximab (Reopro) wasf rom Centocor (Leiden,The Netherlands); AR-C69931MXw as kindly provided by Astra-Zeneca (Charnwood,U K). Z-Gly-Gly-Arga minomethyl coumarin (Z-GGR-AMC) camefrom Bachem (Bubendorf, Switzerland), acetylsalicylic acid(aspirin) fromLorexSynthelabo (Maarssen, The Netherlands); unlabeled and Oregon Green-488 (OG488) labeled annexin A5 (annexin V) from Nexins Research(Hoeven, The Netherlands); recombinant human tissue factor fromDade (Miami, FL, USA). Human thrombin calibrator and thrombogram software were suppliedb ySynapse (Maastricht, The Netherlands). Other reagentsc amef rom Sigma (St. Louis, MO, USA). Fabfragmentsofmonoclonalanti-human GPVI antibody 9O12 were produced and characterized as described (21) . Antiintegrin α 2 β 1m Ab 6F1w as ak ind giftf rom Dr.B .C oller (Mount Sinai Hospital, Boston, MA, USA).
Source and preparation of collagens
Fibrillar 'Horm'type Icollagen, used as reference collagenpreparation,was bought fromNycomed(Munich, Germany).Native fibrillar type-Icollagen wasprepared from bovine tendon, and pepsin-digested to obtain soluble (non-fibrillar) collagen, following ap rocedure described elsewhere ( 20) . Tissue from healthyhuman heart,obtained by autopsy,was kindly provided by Dr.J .Cleutjens (Dept.ofPathology,Maastricht University). Permission wasgiven by the local Medical Ethical Committee. Nativet otal collagenf ibrils were extracted fromh eartt issue, basicallya sd escribed (22) .B riefly, tissue wasw ashed with phosphate-buffered saline containing proteaseinhibitors (10 mg ml -1 EDTA, 1 µ gml -1 pepstatin, 2 µ gml -1 aprotinin and 0.5 µ g ml -1 leupeptin),h omogenized,a nd extracted with 0.5 mol L -1 aceticacid. Themixturewas vigorously shakenat5°C for 24 h, thenfiltered and centrifuged at 48,400 gfor 2h.Collagen fibrils in the supernatant were precipitatedbyaddition of 1.7 MNaCl and a2 4-h incubation at 5°C.A fter 1ho fc entrifugation at 35,000 g, the collagen-containing pelletwas solubilizedin0.5 M acetic acidand dialyzedagainst 0.1 Macetic acid. Fibrillar collagencontent wasdeterminedbySirius red staining.
Isolationofplateletsand plasma
Bloodwas obtainedfrom healthyvolunteersafter fullinformed consent according to the Helsinki declaration. Blood wasdrawn by venapuncture into 1/10 volume of 129 mM trisodium citrate. First 2.5mlofblood were discarded. Theblood wascentrifuged at 260gfor 15 min to obtain PRP, and twiceat870 gfor 10 min for platelet-free plasma (PFP). Platelet concentration wasdeterminedw ith aB eckman MicroDiff18c ounter (Coulter Electronics, Luton, UK). PRP wasn ormalizedt o1 .5×10 8 platelets ml -1 with autologous PFP.
Thrombingeneration measurement
Thrombingeneration wascontinuously measured in PRP using the thrombogram method essentiallyasdescribed (23) .Briefly, triplicatesamples of 80 µ lPRP (1.5×10 8 platelets ml -1 )were pipettedinto wells of a96-wells plate (Immulon 2HB,Dynex, Chantilly,V A, USA), containing 20 µ lt issue factor (3 pmol L -1 )i n buffer A( 20 mM Hepes, 140 mM NaCl,5m gm l -1 BSA, pH 7.35). Platesw ere pre-warmeda t3 7°C in aw ell-plate reader (Molecular Devices), and pre-heated to 37°C for 5min. Coagulation wasstarted by automated addition of 20 µ LofbufferB(20 mM Hepes, 0.1 MCaCl 2 ,60mgml -1 BSA, pH 7.35)containing Z-GGR-AMC (2.5 mM). Final concentrations were 0.5pmol L -1 tissue factor and 0.42 MZ-GGR-AMC. Fluorescence accumulation from cleavedAMC wasc ontinuously measured at excitation and emission wavelengthsof390 and 460 nm, respectively (37°C).First-derivative curvesofaccumulation of fluorescence were converted into curveso fn anomolart hrombin using a human thrombin calibrator and by correction for the fluorescence dueto α 2 -macroglobulin-bound thrombin (24) . PRP was pretreatedw ith antibodieso ri nhibitors at maximallye ffective concentrations for 10 min (37°C).T hrombin generation measurements were startedat10min after collagenaddition. All collagensamples were dialyzed against 10 mM acetic acid(overnight 4°C)before using for thrombin generation.Controls were always runwith vehicle media.
The potencyofcollagen preparations to enhance platelet-dependent thrombin generation wasevaluatedfrom effects on the thrombin peak height. This thrombogram parameter is an indicator of the maximalrateofthrombin formation (23),and is sensitivetoplateletactivation (24) .
Measurement of thrombus formation andPSexposure underflow
Flowe xperiments over collagenw ere performed at room temperature using blood anticoagulated with 40 µΜ PPACK (6, 25) . Collagenpreparations were spread on cleaned glass coverslips at an optimaldensity of 35 µ gcm -2 .After coating for 1hinamoist chamber,the coverslips were rinsed with saline,blockedduring 30 min with Hepes buffer pH 7.45 (inmM: NaCl 136, glucose 10, Hepes5,KCl 2.7, MgCl 2 2, CaCl 2 ,2), supplementedwith 1% BSA, and washeda gain with saline.After staining with Sirius red,t his resulted in about 40% area coverage with red colour. Whole blood wasperfusedfor 4min over the collagensurfaceat am oderately high wall-shear rateo f1 000 s -1 .H igh-resolution transmission and fluorescent imageswere recorded in real-time with aVisitech digitalimaging system(Sunderland,UK). PS exposure wasdetected by post-perfusion with rinsing Hepes buffer pH 7.45 containing 1Um l -1 heparina nd 1 µ gm l -1 OG488-annexin A5.
Phase-contrastand fluorescent images were obtainedfrom at leastten differentcollagen-containing microscopic fields,which were arbitrarily chosen. Area coverage from phase-contrastand fluorescent images wasanalyzedoff-line,asdescribed (6) .
Statistics
Experiments were performed with PRP or blood from at least threed ifferent donors. Statistical indications were made using the Kruskal-Wallis test, followedbyaDunn test for comparison betweentreatments. Dataare means±SE.
Results
Fibrillar but not solubletypeIcollagenenhances thrombin generation in platelet-richplasma
Thrombing eneration in PRP with normalized platelet count, triggered with alow concentration of tissue factor (0.5 pmol L -1 ), reliesonplateletactivation and PS exposure (24) .Wedetermined the effectsofseveral type-I collagenpreparations on platelet-dependent generation of thrombin. Fibrillar Hormtype-Icollagen, whichismostlyusedasareference collagenpreparation to aggregateplatelets (with fibersstabilized in an unpublishedway), greatly enhanced the thrombin-generating process (Fig. 1A) . Addition of 5 µ gm l -1 Horm collagent oP RP resultedi na 1.70±0.06 fold ( n =25) increase in thrombin peakheight, which wasa ccompaniedb yas hortening of the time-to-peak from 22.1±1.0 to 9.4±0.4 min in comparison to the control condition. Addition of 10 µ gm l -1 annexin A5,ap rotein thats pecifically chelates PS (26) , completelya bolished thrombin generation in the presenceo fc ollagen (Fig. 1A) .P lateleti nhibition with cAMP-elevating PGE 1 also abolishedt he collagene ffect,c onfirming it relied on activation of the platelets.
In comparisont oH ormc ollagen, native type-I collagenfibrils (10 µ M) were somewhat less effectiveinenhancing thrombin generation. Also with this purified fibrillar collagen, the time-to-peak wasr educed and the peak heighti ncreased when compared to the control condition (Fig. 1B) .Onthe other hand, asoluble type-Icollagen -obtained by controlledproteolytic digestion of native type-I collagenfibers, lacking the telopeptides and the 'banded'quaternarystructureoffibrillarcollagen (20) -, wasoflittle effect in stimulating thrombin generation.Dose-response curvess howedt hat soluble collagenc oncentrations >20 µ gm l -1 were weaklys timulatory, whereas the Horm and nativetype-Icollagen fiberswere alreadyactiveatabout ten-fold lowerconcentrations (Fig. 1C) . Collagenthat waspurified from human heart tissue,enriched in type-Ifibers, wasalso activein enhancing thrombin generation (Fig. 1D) .
Principally GPVIdeterminesthe enhancementof thrombin generation by fibrillar collagen
To evaluate the importanceo fG PVIf or the effect of collagen fibers, blocking Fabfragmentswere used of the mAb 9O12, directed against the collagen-binding site of humanG PVI ( 21) . Pre-incubation of PRPw ith 50 µ gm l -1 9O12 resultedi nc omplete antagonism of the curve shift in thrombin generation induced by Hormtype-Icollagen ( Fig. 2A) .With both 9O12 Fab and collagenpresent, thrombin generation wasdelayed and reduced to the levelofuntreated, control PRP ( Table 1 ).The blocking anti-α 2mAb 6F1, active in plasma,was used to abolish the contribution of this integrin to collagen-induced activation (6) . Differentlyfrom 9O12, pretreatment of PRP withsaturating 6F1 resultedinanincomplete,25% antagonism of the stimulation of thrombin generation by collagen( Fig. 2A and Table1) . Control experiments indicatedthat neither 9O12 nor 6F1 by itself altered thrombin generation in the absence of collagen.
Thes econdarym ediators, TxA 2 and ADP contribute to the thrombin generation in tissue factor-triggered PRP (24, 27) . To determine their involvement in the collageneffect,PRP waspretreated with aspirinand/or maximallyeffectivedoses of the P2Y 1 and P2Y 12 receptors antagonists, MRS2179 and AR-C69931MX, respectively.Aspirin pre-treatment resultedinpartialr eversal of the collagene ffect on the thrombin peak (Fig.  2B) ;t his is similar to the small inhibitorye ffect of aspirin, reported earlierinthe absence of collagen (24) . Also, pretreatment with AR-C69931MX (but not with MRS2179), caused asmall, reducingeffect on the thrombin peak (Table 1 ).This observation correspondswellwith studiesreporting that-inthe absence of collagen-onlyP2Y 12 contributes to plateletprocoagulant activity in mana nd mouse (27, 28) . Together, these results indicate thatt he collagen-enhanced thrombin generation completely relies on GPVI activity,but canbereinforced by α 2 β 1binding and by releaseofautocrine TxA 2 and ADP.
Activatedintegrin α 2 β 1potentiatesGPVI-mediated thrombin generation
In comparisont ot ype-Ic ollagen fibers, digested non-fibrillar collagenforms aremore stronglydependenton α 2 β 1for platelet binding (13, 20) . The divalent cation Mn 2+ switches α 2 β 1a nd other integrins to ahigheraffinity state by exposing acation-and ligand induced binding site (CLIBS) (29, 30) . Othershaveshown that the affinity of platelet α 2 β 1for soluble collagenissignificantly increased by Mn 2+ treatment (31) . We found thati ncubation of PRPwith 2mMMnCl 2 enhanced the effect of the soluble collagen(5 µ gml -1 )onthrombin generation; the Mn 2+ ions caused amarked decreaseintime-to-peak and a1.12±0.07 fold increase in thrombin peakheight (Fig. 3A) .The stimulation by soluble collagenp lus Mn 2+ wasp artlyr eversed by the anti-α 2 6F1 mAb and more than completely antagonized by anti-GPVI 9O12 fragments (Fig. 3B-C) . In the latter case, the extrai nhibition wasnot due to the simultaneous presenceofMn 2+ and 9O12, as this combination alone did not influencethrombin generation. Possibly,the soluble collagenplus Mn 2+ triggers aplatelet-inhibiting pathway.T ogether,t hese resultsp oint to complete dependencyo ft he stimulating collagen/Mn 2+ effect on GPVI activity.
When Horm type-I collagenfibers were used instead of soluble collagen, pretreatment of PRP with Mn 2+ resultedinasimilarc urve shift. Again, Mn 2+ ions caused a1 .21±0.09 fold increase in thrombin peakheight (Fig. 3C) . The collagen/Mn 2+ effect waslargelyinhibited by anti-α 2antibody and completely inhibitedb ya nti-GPVI 9O12 Fab. To determine whether α 2 β 1 contributest ot he thrombin generation with GPVI-specific agonists, PRPw as stimulatedw ith convulxin (100n gm l -1 ), whichisasnakepeptide causing direct GPVI activation (32). In agreement with earlierdata(24), convulxin treatment resulted in a2.99±0.05 fold ( n =4)increase in the thrombin peak. In the presenceo fa nti-α 2 β 1m Ab 6F1, thec onvulxin effect wash ardly changed to a2.89±0.04 fold increase, pointing to absence of integrin activity.T ogether,t hese experiments thus indicate that α 2 β 1contributes to the effects on thrombin generation of fibril- Fig.1 ). Data arecompared to thecontrol conditionwithout collagen or antagonist (mean±SE, n experimentsin triplicate). 
Peak height (% of control)
100 (25) 169.4±5.6 (20) 95.2±6.6 (5) 150.8±11.1 (4) 144.8±12.8 (6) 136.7±18.8 (4) 168.4±8.3 (6) 133.8±12.3 (5) lar and non-fibrillar collagens butnot of convulxin, likelybyenhancing the activating effect of platelet GPVI.
Integrin α IIbβ 3isnot directlyinvolvedincollagenenhanced thrombin generation
Platelets adhere to collagen-associatedproteinslikeVWF viaintegrin α IIbβ 3. Antagonists of α IIbβ 3s uch as abciximab along with VWFantagonists have beenreported to suppressplateletdependent thrombin generation (33) (34) (35) (36) . In the absence of collagen, we found thatabciximab greatly delayedand diminished the formation of thrombin at amaximallyeffectivedose of 40 µ g ml -1 (Fig. 4A ). In combination with Horm collagen (Fig. 4B) , abciximab slightlyp rolonged the time-to-peak from 9.2±0.4 to 11.8±0.9 min ( n =6); anditpartiallylowered the thrombin peak (from169.4±5.6% to 121.3±6.9% of control level, P <0.01). Notably,incombination with abciximab, anti-GPVI 9O12 further diminished the thrombin generation to give atrace similartothat of abciximab alone (62.7±12.2% of control level).Thus, treatment with 9O12, butnot abciximab, wasneeded to completely antagonize the collagen-enhancing effect on thrombin generation. Theseresults indicatethat the enhancing effect of GPVI is mostly not mediatedby α IIbβ 3and,thus, that the effect of the integrin relies on adistinctmechanism.
Collagenenrichedintype-Ifromhuman hearttissue enhances thrombin generation viaGPVI
In humanmyocardium, collagenisabundantlypresentasanetwork of mostlytype-Ifibrils with fewertype-IIIfibrils (37). For comparison of the above results with bovine type-I collagen, we purified acollagen preparation from human heart tissue.Microscopicobservation of this preparation, spread on glass, showed intense Siriusr ed staining with thin collagenfibers. At maximallye ffectivec oncentration, this fibrillar collagens ignificantly enhanced thrombin generation in PRP:t ime-to-peak shortenedw ith 15.3±2.1 min and peak heighti ncreased by 1.8±0.4 fold (Fig. 1D) .The procoagulant effect of the heart collagenw as almost completelyi nhibited with anti-GPVI mAb 9O12. Thus, GPVI appearstobeakey receptor in the procoagulant activity of this collagend erivedf rom the humanc ardiovascularsystem.
Ty pe-I collagens differentlystimulate PS exposureon adherentplateletsunderflow
Using thef ibrillarH ormc ollagen, it has beend escribed that GPVI is them ajor collagenr eceptor regulating thrombus formation of humanand mouse platelets under flowconditions (6, 25) . Using moderately high shearc onditions (4 min at 1000 s -1 ), checked to be sensitive to GPIbblockade,weperformed aseries of flow experiments where humanblood wasperfused ). Data arepercentages relativetothe thrombinpeak-height undercontrol conditions taken as 100% (mean±SE, n=4-6). * P <0.05. ), staining of the collagensurfaces with Sirius redshowedadense, uniformdistribution of red fibers(for fibrillar collagens) or of small reds pots (soluble collagen). After 4-min perfusion of blood over the fibrillar Hormc ollagen and (bovine) type-Icollagen surfaces, multi-layered platelet aggregateswere detected (Fig. 5) .Perfusion of the blood over soluble type-I collagenr esultedi nf ormation of smaller aggregates, while perfusion over humanh eartc ollagen gave aggregateso f variable sizes.Total surfacearea covered by adherentplateletsearlierdemonstrated to increaseabout linearly in time (10)-was similar forall (fibrillarand soluble) collagens at this timepoint (Table 2) . Staining with OG488-annexin A5, to measure PS expression, wastypicallyhigherfor Hormcollagen (10.5% of surface area covered with fluorescence) thanfor the bovine fibrillar type-Icollagen (3.8% coverage with fluorescence); annexin A5 staining wass till lowerf or the heart (0.7%) and soluble type-I (0.25%) collagen (Fig. 5and Table2) .
GPVI blockade by 9O12 Fabs everelyi mpaired aggregate formation (nots hown) and PS exposure (Table 2 ) on all collagens. However, 9O12 did not reduce plateletadhesion, except forh eartc ollagen (Table 2) . Platelet adhesion to all collagens wasa bolished by combined blockade of GPVI with 9O12 and α 2 β 1with 6F1 mAb (notshown),such as wasdemonstrated earlierf or Hormc ollagen (10) .This suggested that the heart collagenwas limitedinadhesion sites for (unstimulated) α 2 β 1, in a similar waya sr ecently found for (typeI )c ollagen in human plaque tissue (38) .GPVI-dependent adhesion of platelets to the plaque collagencan be suppressedb yb locking of the ADPreceptors, e.g.causing α 2 β 1activation (38) . To determine whether this wasalso the casefor the GPVI-dependent adhesion to heart collagen, flow experiments were performed in the presence of MRS2179 (40 µ M) and AR-C69931MX(20 µ M). Indeed,ADP receptorblockade resultedinagreatlyreduced platelet coverage with heartc ollagen (12±2% of control, mean±SE, n=3). In contrast, the blockersw ere muchlessinhibiting on plateletadhesion to Horma nd fibrillar type-Ic ollagens (131±16% and 89±9% of controls, respectively). ). Adhered platelets were stained post-perfusion withOG488-annexin A5 (0.5 µ gml -1 ). Data show surface area coverage of all platelets (phase contrast) and of fluorescentlabeledplatelets (mean±SE, n =3-4 experimentswithblood from differentdonors). 
Discussion
The present data showthat especiallyfibrillarHormand bovine type-Ic ollagens arep otent stimulators of platelet-dependent thrombin generation in PRP. Thus, under conditionso fc oagulation triggered with tissue factor,plateletinteraction with fibrillar collagens greatly enhances the rate of thrombin generation (correlated with the thrombin peak-height).This potentiating effect of the fibrillar collagens is completely abolishedb yt reatment of PRP with the blocking anti-GPVI mAb 9O12. Accordingly, plateletactivation by the signaling collagenreceptor GPVI playsakeyrole in this procoagulant collageneffect,which is in agreement with earlier observations thatG PVIc auses PS expression on platelets and stimulates prothrombinase activity (3, 13, 21, 25) . We furthershowthat the effect of fibrillar collagen on thrombin generation is antagonizedbyplateletinhibition with PGE 1 and by scavenging PS with annexin A5,indicating that it relies on plateletactivation and subsequent PS expression. We also find that afibrillarcollagen preparation from human heart,e nriched in type Ia nd fewert ype IIIc ollagens, significantly stimulatest hrombin generation in the presenceo fp latelets. Alsointhis case the stimulating effect is blocked by antiGPVImAb and thus relies on GPVI. On theotherhand,asoluble formofbovine type Icollagen, lacking the telopeptides and the typical striated morphology of fibrillar collagen, requiresprior activation of α 2 β 1(withMn 2+ )for stimulation of thrombin generation. The stimulation also in this case ultimatelyr elieso n GPVI, as is concluded from thec omplete suppression by antiGPVImAb.
Soluble type Ic ollagen expresses multiple α 2 β 1b inding sites (8, 20) . It has beendescribed thatMn 2+ ions and weak agonists suchasADP increase thebindingofthis collagentoplatelets by changing α 2 β 1t oa ni ntermediate,h ighera ffinity conformation (9). Our results indicatet hat, not onlyw ith soluble collagenbut also with fibrillar type Icollagen, pre-activation of the integrin with Mn 2+ ions enhances thrombin generation. BecauseG PVIb lockade completelyr everses the effect of collagen/Mn 2+ ,GPVImust actasaprincipal plateletreceptor in all collagen-enhanced procoagulant activity.Inadifferent context, it hasalready been observed thatintegrin activation in interplay withhuman and mouse GPVI regulates plateletaggregation and thrombus formation under conditions where coagulation wasabsent (3-6).These present resultssignificantly extend this work by showing thatactivated α 2 β 1, also under coagulant conditions, enhancest he signaling function of GPVI likelyb yr einforcing platelet contact with collagen. In contrast, theyd on ot provide evidencefor adirect signaling effect via α 2 β 1inthe collagenstimulated thrombin generation.
In the absence of collagen, the secondarym ediators, TxA 2 and ADP,haveamodest stimulatoryeffect on platelet procoagulant activity,notably via stimulation of P2Y 12 receptors (27, 28) . This appearsa lso to be true in thrombin generation measurements with collagenpresent(Table1), possibly by enforcing platelet-collageni nteraction. This modest effect differs from the regulation of plateleta ggregation, where autocrine TxA 2 and ADP are consideredtoberelativelyimportant (39) .
Va riousstudieshavereported thatintegrin α IIbβ 3has asupporting role in platelet-dependent thrombin generation (11, 33) . It is also proposedthat the α IIbβ 3antagonist abciximab affects the procoagulant activity of platelets adheredt oc ollagen (36) . We note aclear lowering effect of abciximabonthrombin generation levels both in the absence and presence of collagen. In addition, we find that the enhancing effect of collagenonthrombin generation persistsi nt he presenceo f α IIbβ 3a ntagonism with abciximab, whichmakes it unlikelythat the integrin is directly involved in the platelet-collageninteractions implicated in procoagulant activity.Abciximab then mayact by interferinginthe interaction of platelets with fibrin(ogen) or coagulation factors.
In general, we find ac orrelation betweenc ollagen-stimulated,PS-dependent thrombin generation in PRP and collageninduced PS exposure under flow(in the absence of coagulation). In either assay,fibrillartype Icollagens aremore active thanthe soluble collagen. Onlythe heart-derivedcollagen is less active in causing PS exposure (but not aggregate formation) under flow thanispredicted from the enhancing effect on thrombin generation. On the otherhand,with allcollagens including the heart collagen, thrombin generation as well as platelet activation (PS exposure)a nd aggregate formation under flow are completely dependent on GPVI activity.
The differencesi ne ffectso ft he collagenp reparations are likelytoreside in the contribution of α 2 β 1. We find that onlyfor heart collagenadhesion under flowreliesonGPVI. Similarlyto the situation with plaque-derivedcollagens (38) ,this maypoint to alow number of interaction sites for the (unactivated) α 2 β 1in-tegrin.Adhesion to the othercollagens is not exclusivelydependent on GPVI, suchi na greement with previous findings with Hormc ollagen (6, 10). However, as described elsewhere, for human as well as murine platelets, GPVIactivity is likelytoplay arole in the stable adhesion to collagens (40) .Others have shown thatsoluble type-Icollagen relies more stronglyon α 2 β 1for platelet adhesion and thrombus formation than 'banded',fibrillar collagen ( 8) . The present resultsa re compatible with the presence of asignificant numberofinteraction sites for (unactivated) α 2 β 1inboth soluble and fibrillar collagen, whichseem to variably allowGPVI-collageninteraction. Together, the results depict aphysiological mechanism, in whichGPVIinteraction with collagenfibers, supportedby α 2 β 1, plays acentral,bridging role in not onlyp rimary thrombus formation, buta lso platelet-dependent coagulation.
